Net profit of Syncom Formulations (India) rose 69.08% to Rs 7.00 crore in the quarter ended December 2023 as against Rs 4.14 crore during the previous quarter ended December 2022. Sales rose 13.52% to Rs 65.14 crore in the quarter ended December 2023 as against Rs 57.38 crore during the previous quarter ended December 2022.
Particulars | Quarter Ended |
| Dec. 2023 | Dec. 2022 | % Var. |
Sales | 65.14 | 57.38 | 14 |
OPM % | 11.28 | 10.28 | - |
PBDT | 10.83 | 7.17 | 51 |
PBT | 9.38 | 5.97 | 57 |
NP | 7.00 | 4.14 | 69 |